Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (354)
SAGE documentation (33)
Scientific publications (4)
Systematic reviews (SYSVAC) (1089)
Regions
Africa (57)
Americas (187)
Eastern Mediterranean (10)
Europe (155)
South-East Asia (10)
Western Pacific (36)
Diseases
COVID-19 (1481)
Chikungunya (9)
Cholera (33)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (12)
Moderate (7)
Low (111)
Critically low (685)
Not applicable (274)
1481 results found
2022
∙
Christoph Steffen, Louise Henaff, Shalini Desai, Noni MacDonald, Anna-Lea Kahn, Christopher Morgan, Folake Olayinka, Ruth Faden
COVID-19 Vaccine Policy Development in a Sample of 44 Countries- Key Findings from a December 2021 Survey of National Immunization Technical Advisory Groups (NITAGs)
2022
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
2022
Vaccination recommendations against COVID-19 for the fall in Spain
2022
∙
NACI
Updated guidance on COVID-19 vaccine booster doses in Canada
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19 in France
2022
∙
ATAGI
COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines
2022
∙
ATAGI
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
2022
∙
Haute Autorité de Santé
Place of the Cominarty bivalent vaccines against Covid-19 Original/Omicron BA.1 and Original/Omicron BA.4-5
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register